Key statistics
As of last trade Cellectar Biosciences Inc (NV4:DUS) traded at 1.48, 2.07% above its 52-week low of 1.45, set on Nov 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.48 |
---|---|
High | 1.48 |
Low | 1.48 |
Bid | 1.54 |
Offer | 1.60 |
Previous close | 1.48 |
Average volume | 3.08k |
---|---|
Shares outstanding | 40.57m |
Free float | 37.02m |
P/E (TTM) | -- |
Market cap | 64.10m USD |
EPS (TTM) | -1.67 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 07:11 GMT.
More ▼
- Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
- Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225
- Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer